Tumor suppressor genes - J. Michael Bishop (UCSF)

TL;DR

Retinoblastoma led to the discovery of tumor suppressor genes.

Transcript

our fifth path to the genetic Paradigm of cancer involved the study of congenital cancer and incidentally uncovered an entirely new form of cancer Gene this work departs from the fact that about 5% of human cancer is strongly hereditary uh and it began with a study of a childhood tumor known as retinoblastoma and here is an example in some instance... Read More

Key Insights

• The study of congenital cancer revealed a new type of cancer gene, leading to the understanding of tumor suppressor genes.
• Approximately 5% of human cancers are strongly hereditary, with retinoblastoma being a key example.
• Retinoblastoma can be inherited, with a defective chromosome 13 playing a crucial role in its development.
• The retinoblastoma gene, or rb1, was identified as a key factor in the development of retinoblastoma.
• Inherited retinoblastoma involves a genetic deficiency, requiring both copies of a gene to be damaged.
• Tumor suppressor genes, when absent, favor the development of cancer, unlike proto-oncogenes that act like a jammed accelerator.
• The discovery of tumor suppressor genes has been enhanced by modern genomic techniques, beyond just studying inherited cancers.
• Tumor suppressor gene deficiencies are genetically recessive, meaning both copies must be affected for cancer to develop.

Questions & Answers

Q: How was the retinoblastoma gene discovered?

The retinoblastoma gene, or rb1, was discovered through the study of congenital cancer, particularly retinoblastoma. A defective chromosome 13 was identified in inherited cases of retinoblastoma, with a specific deletion correlating with the disease. Molecular biology techniques pinpointed the rb1 gene as the key factor in retinoblastoma's development.

Q: What role does chromosome 13 play in retinoblastoma?

Chromosome 13 plays a crucial role in retinoblastoma, particularly in hereditary cases. A specific deletion on this chromosome was found to segregate with the disease, leading to the identification of the rb1 gene. This deletion results in a genetic deficiency that, when both gene copies are affected, leads to the development of retinoblastoma.

Q: What is the difference between tumor suppressor genes and proto-oncogenes?

Tumor suppressor genes act as a faulty brake, preventing cancer when functional, while proto-oncogenes act like a jammed accelerator, promoting cancer when overactive. Tumor suppressor genes are recessive, requiring both copies to be defective for cancer to develop, whereas proto-oncogenes require only one copy to be altered to promote cancer.

Q: How has modern genomics impacted the study of tumor suppressor genes?

Modern genomics has significantly advanced the study of tumor suppressor genes, allowing for their identification without relying solely on hereditary cancer studies. Genomic techniques enable researchers to pinpoint these genes across various cancer types, broadening the understanding of both congenital and sporadic cancers and facilitating targeted cancer therapies.

Q: What is the inheritance pattern of retinoblastoma?

Retinoblastoma can be inherited in a strong manner, with a defective chromosome 13 being passed down in families. This pattern is evident in family trees where the disease segregates with a specific genetic deletion. The inheritance involves a genetic deficiency, requiring both gene copies to be damaged for the cancer to manifest.

Q: Why is retinoblastoma considered a rare tumor?

Retinoblastoma is considered a rare tumor because it requires two rare genetic events: the damage of both copies of the rb1 gene. In the absence of inherited abnormalities, both gene copies must be damaged early in life, making the occurrence of retinoblastoma a rare event, affecting approximately one in 30,000 people.

Q: What is the significance of tumor suppressor gene deficiencies being genetically recessive?

The genetic recessiveness of tumor suppressor gene deficiencies means that both copies of the gene must be affected for cancer to develop. This recessive nature distinguishes tumor suppressor genes from proto-oncogenes and underscores the importance of both genetic copies in maintaining cellular control and preventing cancer.

Q: How do tumor suppressor genes influence cancer development?

Tumor suppressor genes influence cancer development by acting as a regulatory brake on cell growth. When these genes are functional, they prevent uncontrolled cell proliferation. However, when both copies are defective, this regulatory function is lost, creating an environment that favors cancer development, highlighting their crucial role in cancer prevention.

Summary & Key Takeaways

• The investigation into congenital cancer, particularly retinoblastoma, led to the identification of tumor suppressor genes. Retinoblastoma, a childhood tumor, is hereditary in some cases, linked to a deletion on chromosome 13. The absence of the retinoblastoma gene, or rb1, is crucial in the tumor's development.

• Tumor suppressor genes act as a faulty brake, preventing cancer when functional. Their absence, however, encourages cancer development. These genes are typically identified when both copies are defective, indicating a recessive genetic trait. Modern genomics now allows for the identification of these genes without relying solely on hereditary cancer studies.

• Retinoblastoma can occur spontaneously, without inherited abnormalities, when both gene copies are damaged early in life. This rare event highlights the genetic deficiency nature of tumor suppressor genes. The discovery of these genes has broadened the understanding of both congenital and sporadic cancers.